Kavanaugh Taylor E, Werfel Thomas A, Cho Hongsik, Hasty Karen A, Duvall Craig L
Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
University of Tennessee Health Science Center, Memphis, TN, USA.
Drug Deliv Transl Res. 2016 Apr;6(2):132-47. doi: 10.1007/s13346-015-0234-2.
Osteoarthritis (OA) is a disease characterized by degradation of joints with the development of painful osteophytes in the surrounding tissues. Currently, there are a limited number of treatments for this disease, and many of these only provide temporary, palliative relief. In this review, we discuss particle-based drug delivery systems that can provide targeted and sustained delivery of imaging and therapeutic agents to OA-affected sites. We focus on technologies such as polymeric micelles and nano-/microparticles, liposomes, and dendrimers for their potential treatment and/or diagnosis of OA. Several promising studies are highlighted, motivating the continued development of delivery technologies to improve treatments for OA.
骨关节炎(OA)是一种以关节退化并在周围组织中形成疼痛性骨赘为特征的疾病。目前,针对这种疾病的治疗方法有限,而且其中许多方法只能提供暂时的、缓解症状的治疗。在本综述中,我们讨论了基于颗粒的药物递送系统,该系统可以将成像剂和治疗剂靶向并持续递送至受OA影响的部位。我们重点关注聚合物胶束、纳米/微粒、脂质体和树枝状大分子等技术在OA治疗和/或诊断方面的潜力。文中突出介绍了几项有前景的研究,这促使人们继续开发递送技术以改善OA的治疗方法。